131 related articles for article (PubMed ID: 11913357)
1. High dose ratio (HDR) cervical ring applicator to control bleeding from cervical carcinoma.
Grigsby PW; Portelance L; Williamson JF
Int J Gynecol Cancer; 2002; 12(1):18-21. PubMed ID: 11913357
[TBL] [Abstract][Full Text] [Related]
2. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
[TBL] [Abstract][Full Text] [Related]
3. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
4. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
Kim WC; Kim GE; Suh CO; Loh JJ
Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
[TBL] [Abstract][Full Text] [Related]
5. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
6. 3T multiparametric MRI-guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator.
Fredman E; Traughber B; Podder T; Colussi V; Zheng Y; Russo S; Herrmann K; Paspulati R; Waggoner S; Zanotti K; Nagel C; Nakayama J; Machtay M; Ellis R
Brachytherapy; 2018; 17(2):334-344. PubMed ID: 29097137
[TBL] [Abstract][Full Text] [Related]
7. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dose delivered to vagina using two different intracavitary brachytherapy applicators for carcinoma cervix.
Bajwa HK; Talluri AK; Maqbool A; Reddy D; Singareddy R; Sresty NM; Raju AK
Brachytherapy; 2022; 21(2):151-157. PubMed ID: 34756698
[TBL] [Abstract][Full Text] [Related]
9. Results and complications of high dose rate and low dose rate brachytherapy in carcinoma of the cervix: Cerrahpaşa experience.
Okkan S; Atkovar G; Sahinler I; Oner Dinçbaş F; Koca A; Köksal S; Turkan S; Uzel R
Radiother Oncol; 2003 Apr; 67(1):97-105. PubMed ID: 12758245
[TBL] [Abstract][Full Text] [Related]
10. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
[TBL] [Abstract][Full Text] [Related]
11. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
[TBL] [Abstract][Full Text] [Related]
12. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
Lee SW; Suh CO; Chung EJ; Kim GE
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
[TBL] [Abstract][Full Text] [Related]
13. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
14. Spatial reproducibility of the ring and tandem high-dose rate cervix applicator.
Bahena JH; Martinez A; Yan D; Mele E; Edmunson G; Brown D; Hardy M; Brabbins D; Gustafson G
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):13-9. PubMed ID: 9588912
[TBL] [Abstract][Full Text] [Related]
15. High-dose-rate brachytherapy at 14 Gy per hour to point A: preliminary results of a prospectively designed schedule for cancer of the cervix based on the linear-quadratic model.
Leborgne F; Leborgne JH; Zubizarreta E; Fowler JF; Maisonneuve J; Ferrari D; Curochquin R
Int J Gynecol Cancer; 2001; 11(6):445-53. PubMed ID: 11906547
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience.
Tan LT; Coles CE; Hart C; Tait E
Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):175-82. PubMed ID: 19101130
[TBL] [Abstract][Full Text] [Related]
17. Image-Guided Brachytherapy a Comparison Between 192Ir and 60Co Sources in Carcinoma Uterine Cervix.
Sinnatamby M; Kandasamy S; Karunanidhi G; Neelakandan V; Ramapandian S; Kannan M; Sampath E
Gulf J Oncolog; 2022 Jan; 1(38):7-14. PubMed ID: 35156639
[TBL] [Abstract][Full Text] [Related]
18. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
19. Assessment of uterus position as a surrogate for high-risk clinical target volume with respect to the applicator position for multiple fractions of brachytherapy in cervical cancer.
Cooper R; Brearley E; Hurmuz P; Musunuru HB; Richardson C; Swift S; Orton J; Bownes P
Arch Gynecol Obstet; 2014 Dec; 290(6):1201-5. PubMed ID: 25001571
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme.
Wang CJ; Leung SW; Chen HC; Sun LM; Fang FM; Changchien CC; Huang EY; Wu JM; Chen CC
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):391-8. PubMed ID: 9226328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
